Daphne Quimi

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ Douglas Carr, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daphne Quimi:

Form 4 holding Chief Financial Officer

AMICUS THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
398,532
Estimated value
$4,926,692
Report date
18 Jan 2023
Price
$12.36
Ownership
Direct
Form 4 holding Chief Financial Officer

AMICUS THERAPEUTICS, INC.

Security class
Stock Options (right to buy)
Shares / value
130,480
Estimated value
Report date
03 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Daphne Quimi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .